Oncotherapeutics (United States)

243 papers and 6.5k indexed citations i.

About

In recent decades, authors affiliated with Oncotherapeutics (United States) have published 243 papers, which have received a total of 6.5k indexed citations. Scholars at this organization have produced 119 papers in Hematology, 95 papers in Molecular Biology and 90 papers in Oncology on the topics of Multiple Myeloma Research and Treatments (109 papers), Protein Degradation and Inhibitors (37 papers) and Peptidase Inhibition and Analysis (35 papers). Their work is cited by papers focused on Molecular Biology (2.3k citations), Immunology (1.9k citations) and Oncology (1.6k citations). Authors at Oncotherapeutics (United States) collaborate with scholars in United States, United Kingdom and Canada and have published in prestigious journals including Science, Cell and Proceedings of the National Academy of Sciences. Some of Oncotherapeutics (United States)'s most productive authors include James R. Berenson, Hua Yu, Lin Wang, Tangsheng Yi, Drew M. Pardoll, Marcin Kortylewski, Defu Zeng, Regina A. Swift, Henry C. Marsh and Una Ryan.

In The Last Decade

Fields of papers published by authors at Oncotherapeutics (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Oncotherapeutics (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Oncotherapeutics (United States) at the time of their publication.

Countries citing scholars working at Oncotherapeutics (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Oncotherapeutics (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Oncotherapeutics (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oncotherapeutics (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025